As of Apr 29
| +0.06 / +0.19%|
The 22 analysts offering 12-month price forecasts for Merck KGaA have a median target of 35.33, with a high estimate of 42.72 and a low estimate of 30.83. The median estimate represents a +13.71% increase from the last price of 31.07.
The current consensus among 25 polled investment analysts is to Buy stock in Merck KGaA. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.